000 | 01814 a2200457 4500 | ||
---|---|---|---|
005 | 20250517145811.0 | ||
264 | 0 | _c20170818 | |
008 | 201708s 0 0 eng d | ||
022 | _a1420-9071 | ||
024 | 7 |
_a10.1007/s00018-017-2502-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJavadov, Sabzali | |
245 | 0 | 0 |
_aMitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection? _h[electronic resource] |
260 |
_bCellular and molecular life sciences : CMLS _c08 2017 |
||
300 |
_a2795-2813 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
650 | 0 | 4 | _aPeptidyl-Prolyl Isomerase F |
650 | 0 | 4 |
_aCyclophilins _xantagonists & inhibitors |
650 | 0 | 4 | _aDrug Discovery |
650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
650 | 0 | 4 |
_aHeart _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMitochondrial Membrane Transport Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aMitochondrial Permeability Transition Pore |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aMyocardial Ischemia _xdrug therapy |
650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xdrug therapy |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 |
_aProtein Interaction Maps _xdrug effects |
650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
700 | 1 | _aJang, Sehwan | |
700 | 1 | _aParodi-Rullán, Rebecca | |
700 | 1 | _aKhuchua, Zaza | |
700 | 1 | _aKuznetsov, Andrey V | |
773 | 0 |
_tCellular and molecular life sciences : CMLS _gvol. 74 _gno. 15 _gp. 2795-2813 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00018-017-2502-4 _zAvailable from publisher's website |
999 |
_c27050309 _d27050309 |